Latest filing published 23 Nov 2022 for NeuroPace Inc, €476k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +458.4%Entry US$1.61 · Close at T+365 US$8.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Accelmed Partners II L.P.: trading record in brief
Accelmed Partners II L.P. discloses dealings in NeuroPace Inc to SEC (Form 4). The record holds 4 filings, for trades running from 21 April 2021 to 22 November 2022.
On the market, this insider has only ever bought: 3 purchases, €8.9M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2022 alone, the filings show 2 purchases and no sales.
A typical purchase (the median) is worth €476k. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 23 November 2022 with an open-market purchase (€476k) in NeuroPace Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Accelmed Partners II L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 327,893 shares@ US$1.499100.0% of flowCommon StockSEC:0000899243-22-036949:0Canonical exit: 19 Feb 2023 (T+90)
- 62,398 shares@ US$1.4991.0% of flowCommon StockSEC:0000899243-22-036949:1Canonical exit: 20 Feb 2023 (T+90)
- 3,454,422 shares0Common StockSEC:0001209191-21-028327:0
- 588,235 shares@ US$17.0094.6% of flowCommon StockSEC:0001209191-21-028192:0Canonical exit: 20 Jul 2021 (T+90)
4 of 3 declarations
